The protective effects of ginsenoside Rg1 against hypertension target-organ damage in spontaneously hypertensive rats

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Chen, Hui ^a,b   Yin, Jun ^b   Deng, Yanpin ^a   Yang, Min ^a   Xu, Lingling ^a   Teng, Fukang ^a,b   Li, Defang ^a   Cheng, Yufan ^c   Liu, Sha ^d   Wang, Dong ^b   Zhang, Tingting ^a,b   Wu, Wanying ^a   Liu, Xuan ^a   Guan, Shuhong ^a   Jiang, Baohong ^a   Guo, Dean ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Ginsenoside Rg1; Hypertension; Hypertensive complication; Vascular remodeling

Indexed keywords

GINSENOSIDE RG 1; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GLOMERULAR STRUCTURE; HEART INJURY; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MALE; NONHUMAN; RAT; RETINA BLOOD VESSEL; SPONTANEOUSLY HYPERTENSIVE RAT; TRANSMISSION ELECTRON MICROSCOPY; WISTAR KYOTO RAT;

EID: 84860138468     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-53     Document Type: Article

References (41)

1. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008, 52(5):818-827. 10.1161/HYPERTENSIONAHA.108.113357, 18852389.
2. Ezzati M, Lopex AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002, 360(9343):1347-1360. 10.1016/S0140-6736(02)11403-6, 12423980.
3. Yamori Y. Implication of hypertensive rat models for primordial nutritional prevention of cardiovascular diseases. Clin Exp Pharmacol Physiol 1999, 26(7):568-572. 10.1046/j.1440-1681.1999.03085.x, 10405792.
4. Dong TT, Cui XM, Song ZH, Zhao KJ, Ji ZN, Lo CK, Tsim KW. Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem 2003, 51(16):4617-4623. 10.1021/jf034229k, 14705886.
5. Ng TB. Pharmacological activity of sanchi ginseng (Panax notoginseng). J Pharm Pharmacol 2006, 58(8):1007-1019.
6. Sun HX, Pan HJ, Pan YJ. Haemolytic activities and immunologic adjuvant effect of Panax notoginseng saponins. Acta Pharmacol Sin 2003, 24(11):1150-1154.
7. Gillis CN. Panax ginseng pharmacology: A nitric oxide link?. Biochem Pharmacol 1997, 54(1):1-8. 10.1016/S0006-2952(97)00193-7, 9296344.
8. Xie XS, Yang M, Liu HC, Zuo C, Li HJ, Fan JM. Ginsenoside Rg1, a major active component isolated from Panax notoginseng, restrains tubular epithelial to myofibroblast transition in vitro. J Ethnopharmacol 2009, 122(1):35-41. 10.1016/j.jep.2008.11.020, 19101622.
9. Zhang HG, Li XH, Yang ZC. Effects of Panax notoginseng saponins on myocardial Gsalpha mRNA expression and ATPase activity after severe scald in rats. Burns 2003, 29(6):541-546. 10.1016/S0305-4179(03)00143-8, 12927977.
10. Park WH, Lee SK, Kim CH. A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats. Life Sci 2005, 76(15):1675-1690. 10.1016/j.lfs.2004.07.030, 15698847.
11. Yang CY, Wang J, Zhao Y, Shen L, Jiang X, Xie ZG, Liang N, Zhang L, Chen ZH. Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components. J Ethnopharmacol 2010, 130(2):231-236. 10.1016/j.jep.2010.04.039, 20435129.
12. Chen SW, Li XH, Ye KH, Jiang ZF, Ren XD. Total saponins of Panax notoginseng protected rabbit iliac artery against balloon endothelial denudation injury. Acta Pharmacol Sin 2004, 25(9):1151-1156.
13. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, Yeung HW, Wong RN, Sasisekharan R, Fan TP. Modulating angiogenesis: The yin and the yang in ginseng. Circulation 2004, 110(10):1219-1225. 10.1161/01.CIR.0000140676.88412.CF, 15337705.
14. Lu MC, Lai TY, Hwang JM, Chen HT, Chang SH, Tsai FJ, Wang HL, Lin CC, Kuo WW, Huang CY. Proliferation-and migration-enhancing effects of ginseng and ginsenoside Rg1 through IGF-I- and FGF-2-signaling pathways on RSC96 Schwann cells. Cell Biochem Funct 2009, 27(4):186-192. 10.1002/cbf.1554, 19326380.
15. Ma ZC, Gao Y, Wang YG, Tan HL, Xiao CR, Wang SQ. Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-alpha. Acta Pharmacol Sin 2006, 27(8):1000-1006. 10.1111/j.1745-7254.2006.00331.x, 16867250.
16. Leung KW, Pon YL, Wong RN, Wong AS. Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells. J Biol Chem 2006, 281(47):36280-36288. 10.1074/jbc.M606698200, 17008323.
17. Yin H, Liu Z, Li F, Ni M, Wang B, Qiao Y, Xu X, Zhang M, Zhang J, Lu H, Zhang Y. Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction. J Mol Med 2011, 89(4):363-375. 10.1007/s00109-011-0723-9, 21327539.
18. Kim YH, Lee YG, Choi KJ, Uchida K, Suzuki Y. Transglycosylation to ginseng saponins by cyclomaltodextrin glucanotransferases. Biosci Biotechnol Biochem 2001, 65(4):875-883. 10.1271/bbb.65.875, 11388467.
19. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation 2003, 108(18):2230-2235. 10.1161/01.CIR.0000095031.51492.C5, 14557363.
20. Mercier N, Labat C, Louis H, Cattan V, Benetos A, Safar ME, Lacolley P. Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats. Am J Hypertens 2007, 20(3):319-325. 10.1016/j.amjhyper.2006.09.002, 17324746.
21. Yu CM, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998, 98(23):2621-2628. 10.1161/01.CIR.98.23.2621, 9843472.
22. Susic D, Frohlich ED, Kobori H, Shao W, Seth D, Navar LG. Salt-induced renal injury in SHRs is mediated by AT1 receptor activation. J Hypertens 2011, 29(4):716-723. 10.1097/HJH.0b013e3283440683, 3053430, 21346625.
23. Mimran A, du Cailar G. Dietary sodium: the dark horse amongst cardiovascular and renal risk factors. Nephrol Dial Transplant 2008, 23(7):2138-2141. 10.1093/ndt/gfn160, 18456679.
24. Leenen FH, Yuan B. Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat. J Hypertens 1998, 16(6):885-892. 10.1097/00004872-199816060-00020, 9663929.
25. Vilela-Martin JF, Vaz-de-Melo RO, Kuniyoshi CH, Abdo AN, Yugar-Toledo JC. Hypertensive crisis: clinical-epidemiological profile. Hypertens Res 2011, 34(3):367-371. 10.1038/hr.2010.245, 21160483.
26. Ishimitsu T, Honda T, Ohno E, Furukata S, Sudo Y, Nakano N, Takahashi T, Ono H, Matsuoka H. Year-long antihypertensive therapy with candesartan completely prevents development of cardiovascular organ injuries in spontaneously hypertensive rats. Int Heart J 2010, 51(5):359-364. 10.1536/ihj.51.359, 20966610.
27. Hajdu MA, Baumbach GL. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol 1994, 266(3):H1027-H1033.
28. Behbahani J, Thandapilly SJ, Louis XL, Huang Y, Shao Z, Kopilas MA, Wojciechowski P, Netticadan T, Anderson HD. Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat. Am J Hypertens 2010, 23(12):1273-1278. 10.1038/ajh.2010.161, 20671721.
29. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001, 38(3):581-587. 10.1161/hy09t1.096249, 11566935.
30. Feihl F, Liaudet L, Waeber B. The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep 2009, 11(3):182-189. 10.1007/s11906-009-0033-6, 19442327.
31. Sonoyama K, Greenstein A, Price A, Khavandi K, Heagerty T. Vascular remodeling: implications for small artery function and target organ damage. Ther Adv Cardiovasc Dis 2007, 1(2):129-137. 10.1177/1753944707086358, 19124402.
32. Ferrario CM, Flack JM. Pathologic consequences of increased angiotensin II activity. Cardiovasc Drugs Ther 1996, 10(5):511-518. 10.1007/BF00050990, 8950064.
33. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004, 17(12):1192-1200. 10.1016/j.amjhyper.2004.05.023, 15607629.
34. Kannel WB. Fifty years of framingham study contributions to understanding hypertension. J Hum Hypertens 2000, 14(2):83-90. 10.1038/sj.jhh.1000949, 10723112.
35. Bohle A, Muller GA, Wehrmann M, Mackensen-Haen S, Xiao JC. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl 1996, 54:S2-S9.
36. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001, 19(5):921-930. 10.1097/00004872-200105000-00013, 11393676.
37. Burlew BS, Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz 2002, 27(2):92-98. 10.1007/s00059-002-2354-y, 12025467.
38. Brooks WW, Conrad CH, Robinson KG, Colucci WS, Bing OH. L-arginine fails to prevent ventricular remodeling and heart failure in the spontaneously hypertensive rat. Am J Hypertens 2009, 22(2):228-234. 10.1038/ajh.2008.334, 19057517.
39. Shen L, Han JZ, Li C, Yue SJ, Liu Y, Qin XQ, Liu HJ, Luo ZQ. Protective effect of ginsenoside Rg1 on glutamate-induced lung injury. Acta Pharmacol Sin 2007, 28(3):392-397. 10.1111/j.1745-7254.2007.00511.x, 17303002.
40. Najeeb UR, Mehmood MH, Alkharfy KM, Gilani AH. Prokinetic and laxative activities of lepidium sativum seed extract with species and tissue selective gut stimulatory actions. J Ethnopharmacol 2011, 134(3):878-883. 10.1016/j.jep.2011.01.047, 21296647.
41. Ghayur MN, Gilani AH. Species differences in the prokinetic effects of ginger. Int J Food Sci Nutr 2006, 57(1-2):65-73.